Evidence map›Paper›PMID 31576474›Full record

ArticleMolecular diversity2020

Cascade process for direct synthesis of indeno[1,2-b]furans and indeno[1,2-b]pyrroles from diketene and ninhydrin.

Atieh Rezvanian, Fatemeh Moradi, Vahideh Zadsirjan, Masoumeh Mohammadnejad, Majid M Heravi

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Molecular diversity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Preparation and antimicrobial activity of Mono-, Bis, and Tris-4,9-Dihydroxy-7,7-Dimethyl-5-(mono-substituted-aryl)-Hexahydro-Indeno[1,2-b]Indole-9,10-Dione derivatives.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Atieh RezvanianPhysics and Chemistry Faculty, Alzahra University, Tehran, Iran. Rezvaniana@alzahra.ac.ir.ORCID http://orcid.org/0000-0001-7774-3249
Fatemeh MoradiPhysics and Chemistry Faculty, Alzahra University, Tehran, Iran.
Vahideh ZadsirjanPhysics and Chemistry Faculty, Alzahra University, Tehran, Iran.
Masoumeh MohammadnejadPhysics and Chemistry Faculty, Alzahra University, Tehran, Iran.
Majid M HeraviPhysics and Chemistry Faculty, Alzahra University, Tehran, Iran.
Alzahra University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Novel and efficient multicomponent reactions (MCRs) involving diketene, ninhydrin (indane-1,2,3-trione) and one primary amine (3CR) or two different primary amines (4CR) were achieved for the successful synthesis of dihydro-4H-indeno[1,2-b]furan-3-carboxamides or tetrahydroindeno[1,2-b]pyrrole-3-carboxamides, respectively. The merits of this method are highlighted by using either commercially available or easily accessible starting materials, operational simplicity, facile workup procedure, efficient usage of all the reactants, tolerance of a variety of functional groups and ability to conduct under un-catalyzed reaction condition. The products were also isolated by just decantation of the solvent, and for the purification column chromatography was non-required.

Indexed as

AminesCatalysisFuransLactonesNinhydrinPyrrolesAminesdiketeneFuransLactonesNinhydrinPyrrolesDihydro-4H-indeno[1,2-b]furan-3-carboxamidesDiketeneNinhydrin (indane-1,2,3-trione)Primary amineTetrahydroindeno[1,2-b]pyrrole-3-carboxamides

Identifiers

PMID31576474
OpenAlexW2978405962

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.